Brief: Glenmark Pharma Approves Transfer Of Nebulizer Brands/Ip Portfolio To Unit
29/05/2026 16:32
BRIEF-Glenmark Pharma Approves Transfer Of Nebulizer Brands/Ip Portfolio To Unit May 29 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:
APPROVES TRANSFER OF NEBULIZER BRANDS/IP PORTFOLIO TO UNIT
Source text: [ID:]
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Glenmark Pharmaceuticals Inc Usa Launches Methylene Blue Injection Usp, 50 Mg/10 Ml Single-Dose Vial
Brief: Glenmark Pharma Launches Winlevi 10 Mg/G Cream In Key European Markets
Brief: Glenmark Pharma Says Glenmark Pharmaceuticals USA Launches Lacosamide Injection USP
Brief: Glenmark Pharma Approves Transfer Of Nebulizer Brands/Ip Portfolio To Unit
Brief: Glenmark Pharma Q4 Consol Net Profit 3.01 Billion Rupees